Growth Metrics

Moderna (MRNA) Tax Rate (2018 - 2025)

Moderna (MRNA) has disclosed Tax Rate for 8 consecutive years, with 3.38% as the latest value for Q4 2025.

  • On a quarterly basis, Tax Rate fell 878.0% to 3.38% in Q4 2025 year-over-year; TTM through Dec 2025 was 1.95%, a 323.0% decrease, with the full-year FY2025 number at 1.95%, down 323.0% from a year prior.
  • Tax Rate was 3.38% for Q4 2025 at Moderna, up from 6.95% in the prior quarter.
  • In the past five years, Tax Rate ranged from a high of 125.9% in Q1 2023 to a low of 210.0% in Q4 2023.
  • A 5-year average of 2.03% and a median of 6.17% in 2021 define the central range for Tax Rate.
  • Peak YoY movement for Tax Rate: plummeted -22148bps in 2023, then soared 21541bps in 2024.
  • Moderna's Tax Rate stood at 10.02% in 2021, then grew by 15bps to 11.48% in 2022, then tumbled by -1929bps to 210.0% in 2023, then soared by 103bps to 5.41% in 2024, then plummeted by -163bps to 3.38% in 2025.
  • Per Business Quant, the three most recent readings for MRNA's Tax Rate are 3.38% (Q4 2025), 6.95% (Q3 2025), and 0.86% (Q2 2025).